Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
Open Access
- 21 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in npj Breast Cancer
- Vol. 7 (1), 1-6
- https://doi.org/10.1038/s41523-020-00214-4
Abstract
The Carolina Breast Cancer Study (CBCS) phases I–II was a case-control study of biological and social risk factors for invasive breast cancer that enrolled cases and controls between 1993 and 1999. Case selection was population-based and stratified by ancestry and age at diagnosis. Controls were matched to cases by age, self-identified race, and neighborhood of residence. Sequencing genomic DNA from 1370 cases and 1635 controls yielded odds ratios (with 95% confidence limits) for breast cancer of all subtypes of 26.7 (3.59, 189.1) for BRCA1, 8.8 (3.44, 22.48) for BRCA2, and 9.0 (2.06, 39.60) for PALB2; and for triple-negative breast cancer (TNBC) of 55.0 (7.01, 431.4) for BRCA1, 12.1 (4.18, 35.12) for BRCA2, and 10.8 (1.97, 59.11) for PALB2. Overall, 5.6% of patients carried a pathogenic variant in BRCA1, BRCA2, PALB2, or TP53, the four most highly penetrant breast cancer genes. Analysis of cases by tumor subtype revealed the expected association of TNBC versus other tumor subtypes with BRCA1, and suggested a significant association between TNBC versus other tumor subtypes with BRCA2 or PALB2 among African-American (AA) patients [2.95 (1.18, 7.37)], but not among European-American (EA) patients [0.62 (0.18, 2.09)]. AA patients with pathogenic variants in BRCA2 or PALB2 were 11 times more likely to be diagnosed with TNBC versus another tumor subtype than were EA patients with pathogenic variants in either of these genes (P = 0.001). If this pattern is confirmed in other comparisons of similarly ascertained AA and EA breast cancer patients, it could in part explain the higher prevalence of TNBC among AA breast cancer patients.Keywords
Funding Information
- Breast Cancer Research Foundation
- American Cancer Society
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (5R35CA197458, P50CA058223, P50CA058223)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
- U.S. Department of Health & Human Services | NIH | National Cancer Institute
This publication has 29 references indexed in Scilit:
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencingProceedings of the National Academy of Sciences of the United States of America, 2011
- Accurate and exact CNV identification from targeted high-throughput sequence dataBMC Genomics, 2011
- Replication of GWAS “Hits” by Race for Breast and Prostate Cancers in European Americans and African AmericansFrontiers in Genetics, 2011
- Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencingProceedings of the National Academy of Sciences of the United States of America, 2010
- Ancestry informative marker sets for determining continental origin and admixture proportions in common populations in AmericaHuman Mutation, 2008
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJama-Journal Of The American Medical Association, 2006
- Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast CancerJNCI Journal of the National Cancer Institute, 2003
- Participation Rates in a Case-Control Study:: The Impact of Age, Race, and Race of InterviewerAnnals of Epidemiology, 1999
- ATM Mutations and Phenotypes in Ataxia-Telangiectasia Families in the British Isles: Expression of Mutant ATM and the Risk of Leukemia, Lymphoma, and Breast CancerAmerican Journal of Human Genetics, 1998